Recent Blog Articles

Keeping weight-loss drugs in perspective

April 01, 2006

If you're dangerously overweight, diet pills may help — but not without major lifestyle changes.

Diet drugs have gotten a lot of press lately. In January 2006, a federal advisory panel recommended that the FDA make available, over the counter, a popular prescription weight-loss medication, orlistat (Xenical). The FDA usually takes the panel's advice, but approval of the orlistat (which would be called Alli) is not a sure thing. Many question the drug's effectiveness in a broader setting; others worry about its side effects. Considerable excitement surrounds rimonabant (Acomplia), a type of weight-loss drug that works by blocking the same receptors in the brain that cause the "munchies" in marijuana users. Rimonabant reduces weight, quiets food cravings, and improves cholesterol and other risk factors for heart disease, including waist circumference.

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.